Evidence map›Paper›PMID 21890822›Full record

ArticleCancer research2011

A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.

Shinya Ohashi, Mitsuteru Natsuizaka, Seiji Naganuma, Shingo Kagawa, Sotai Kimura, Hiroshi Itoh, Ross A Kalman, Momo Nakagawa, Douglas S Darling, Devraj Basu and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Laminin α5: a key factor in tumor metastasis.Clinical & experimental metastasis · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. NOTCH and Esophageal Squamous Cell Carcinoma.Advances in experimental medicine and biology · 2021
    Review
  12. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Shinya OhashiGastroenterology Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mitsuteru Natsuizaka
Seiji Naganuma
Shingo Kagawa
Sotai Kimura
Hiroshi Itoh
Ross A Kalman
Momo Nakagawa
Douglas S Darling
Devraj Basu
Phyllis A Gimotty
Andres J Klein-Szanto
J Alan Diehl
Meenhard Herlyn
Hiroshi Nakagawa
The Wistar Institute · USKitano Hospital · JPUniversity of Fukui · JPUniversity of Louisville · USFox Chase Cancer Center · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REBECCA G WELLS · 1997 to 2026
$32.5M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RUSTGI, ANIL K · 2003 to 2023
$31.7M
Strategic Vision & Impact on Environmental HealthP30ES014443 · NIEHS · UNIVERSITY OF LOUISVILLE · PI RAMOS, KENNETH S. · 2007 to 2010
$4.4M
Mathematical Model of Parotid Acinar DifferentiationR01DE019243 · NIDCR · UNIVERSITY OF LOUISVILLE · PI DARLING, DOUGLAS S, REMPALA, GRZEGORZ A · 2008 to 2012
$2.2M
The molecular regulation of IGFBP-3 in esophageal epthelial cellsR01DK077005 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI NAKAGAWA, HIROSHI · 2007 to 2011
$1.3M
NCI NIH HHS P01 CA098101NCI NIH HHS P01-CA-098101NCI NIH HHS P30 CA016520NIDCR NIH HHS R01DE01923NIDCR NIH HHS R01 DE019243NIDDK NIH HHS P30 DK050306NIDDK NIH HHS P30-DK050306NIDDK NIH HHS R01 DK077005NIDDK NIH HHS R01DK077005NIEHS NIH HHS P30 ES014443NIEHS NIH HHS P30ES014443
6 · The paper itself

Abstract

Zinc finger E-box-binding (ZEB) proteins ZEB1 and ZEB2 are transcription factors essential in TGF-β-mediated senescence, epithelial-to-mesenchymal transition (EMT), and cancer stem cell functions. ZEBs are negatively regulated by members of the miR-200 microRNA family, but precisely how tumor cells expressing ZEBs emerge during invasive growth remains unknown. Here, we report that NOTCH3-mediated signaling prevents expansion of a unique subset of ZEB-expressing cells. ZEB expression was associated with the lack of cellular capability of undergoing NOTCH3-mediated squamous differentiation in human esophageal cells. Genetic inhibition of the Notch-mediated transcriptional activity by dominant-negative Mastermind-like 1 (DNMAML1) prevented squamous differentiation and induction of Notch target genes including NOTCH3. Moreover, DNMAML1-enriched EMT-competent cells exhibited robust upregulation of ZEBs, downregulation of the miR-200 family, and enhanced anchorage-independent growth and tumor formation in nude mice. RNA interference experiments suggested the involvement of ZEBs in anchorage-independent colony formation, invasion, and TGF-β-mediated EMT. Invasive growth and impaired squamous differentiation were recapitulated upon Notch inhibition by DNMAML1 in organotypic three-dimensional culture, a form of human tissue engineering. Together, our findings indicate that NOTCH3 is a key factor limiting the expansion of ZEB-expressing cells, providing novel mechanistic insights into the role of Notch signaling in the cell fate regulation and disease progression of esophageal squamous cancers.

Indexed as

AnimalsAntigens, CDCadherinsCarcinoma, Squamous CellCell DivisionCell Line, TumorDNA-Binding ProteinsEpithelial-Mesenchymal TransitionEsophageal NeoplasmsGene Expression Regulation, NeoplasticHomeodomain ProteinsHumansMiceMice, NudeMicroRNAsNeoplasm ProteinsAntigens, CDCadherinsCDH1 protein, humanDNA-Binding ProteinsHomeodomain ProteinsMAML1 protein, humanMicroRNAsMIR205, humanMIRN200 microRNA, humanNeoplasm ProteinsNOTCH3 protein, humanReceptor, Notch3Receptors, NotchRecombinant Fusion ProteinsRepressor ProteinsRNA, NeoplasmRNA, Small InterferingTranscription FactorsZEB1 protein, humanZEB2 protein, humanZinc Finger E-box-Binding Homeobox 1Zinc Finger E-box Binding Homeobox 2

Identifiers

PMID21890822
PMCPMC3206139
OpenAlexW2003644112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.